Skip to main content
Figure 3 | BMC Health Services Research

Figure 3

From: The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study

Figure 3

Costs associated with total, inappropriate, and pharmacist-preventable inappropriate IV ciprofloxacin doses. p = 0.001 for difference in potential cost avoidance of inappropriate IV ciprofloxacin doses between phases. p = 0.001 for difference in potential cost avoidance of pharmacist-preventable inappropriate IV ciprofloxacin doses between phases.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us